Register entry

NextWave Pharmaceuticals, Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
13
Live patents
37
Countries
0
Catalogue

Drug listings by form and route

13

13 active NDC listings: 13 human prescription drug. By marketing category: NDA 13.

Dosage formNDCs
suspension, extended release6
tablet, extended release4
tablet, chewable, extended release3
RouteNDCs
oral13
Labeller name on the listingNDCs
nextwave pharmaceuticals, inc13
Exclusivity

Patents and exclusivities

37
PatentProductCoversExpiry
8202537QUILLICHEW ERmethylphenidate hydrochlorideproductMar 2027
8062667QUILLIVANT XRmethylphenidate hydrochlorideproductMar 2029
8287903QUILLICHEW ER, QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
8465765QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
8563033QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
8778390QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
8956649QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
9040083QUILLIVANT XRmethylphenidate hydrochlorideproductFeb 2031
10857143QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
11103494QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
11103495QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
11633389QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
8999386QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
9295642QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
9545399QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
9844544QUILLICHEW ERmethylphenidate hydrochlorideproductAug 2033
Catalogue

Marketed products

13
BrandGeneric nameForm / routeNDC
DYANAVEL XRamphetaminetablet, extended release, oral24478-106NDA
DYANAVEL XRamphetaminetablet, extended release, oral24478-108NDA
DYANAVEL XRamphetaminetablet, extended release, oral24478-109NDA
DYANAVEL XRamphetaminetablet, extended release, oral24478-110NDA
Dyanavel XRamphetaminesuspension, extended release, oral24478-102NDA
ONYDA XRClonidine hydrochloridesuspension, extended release, oral24478-148NDA
QuilliChew ERmethylphenidate hydrochloridetablet, chewable, extended release, oral24478-074NDA
QuilliChew ERmethylphenidate hydrochloridetablet, chewable, extended release, oral24478-075NDA
QuilliChew ERmethylphenidate hydrochloridetablet, chewable, extended release, oral24478-076NDA
Quillivant XRmethylphenidate hydrochloridesuspension, extended release, oral24478-321NDA
Quillivant XRmethylphenidate hydrochloridesuspension, extended release, oral24478-322NDA
Quillivant XRmethylphenidate hydrochloridesuspension, extended release, oral24478-323NDA
Quillivant XRmethylphenidate hydrochloridesuspension, extended release, oral24478-324NDA
Compare

Other companies listing methylphenidate hydrochloride

Enquiry

Common questions

Is NextWave Pharmaceuticals, Inc FDA approved?
NextWave Pharmaceuticals, Inc holds no registered establishment of its own; 13 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does NextWave Pharmaceuticals, Inc make?
13 products are listed under NextWave Pharmaceuticals, Inc in the openFDA NDC Directory, most often as suspension, extended release; tablet, extended release; tablet, chewable, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.